To continue using this website, please tell us a
little about yourself:

This site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about cookies on the website and how to delete cookies, see our Privacy and Cookie Policy.

I accept the FE Trustnet cookie policy

For more information Click here




It's look like you're leaving us

What would you like us to do with the funds you've selected

Show me all my options Forget them Save them
Customise this table

How are you reacting to the recent changes to Stewart Investors’ flagship funds?

Considering selling
Doing nothing
Considering buying


You are here: Factsheet

FL AXA Framlington Health PSB

3 FE Trustnet

FE Crown Rating

Fund Objective

Capital growth through investment in healthcare and medical services and product companies worldwide. Investment will be in producers of pharmaceuticals, biotechnology firms, medical device and instrument manufacturers, distributors of healthcare products, care providers and managers and other healthcare services companies.

Fund Manager

Dani Saurymper

Fund Manager




Primary Asset Class

Fund Size

GBP 0.03m as at 24-Oct-2013

Unit Name

FL AXA Framlington Health PSB





Initial Charge


Unit Currency




Annual Charge



GBX 281.20

Change (Mid)

1.20 (0.43%)

Unit LaunchDate


Performance Overview

Performance Charts

Cumulative Performance

  YTD 3m 6m 1y 3y 5y
Fund 7.32 -0.50 -3.35 8.07 72.90 107.79
Sector 2.42 3.53 -2.28 1.87 20.19 23.49

Discrete Performance (%)

  2014 2013 2012 2011 2010
Fund 25.07 29.46 9.60 4.28 15.27
Sector 5.16 10.14 6.76 -5.30 8.11

Asset Allocation

breakdown chart
  Asset Class % of Fund
North American Equities 66.24
Europe ex UK Equities 16.35
UK Equities 9.99
Money Market 3.30
Global Emerging Market Equities 1.76
Japanese Equities 1.65
Asia Pacific ex Japan Equities 0.71

Regional Breakdown

breakdown chart
  Region % of Fund
North America 66.24
Europe Ex UK 16.35
UK 9.99
Cash 3.30
Emerging 1.76
Japan 1.65
Developed Asia Pacific ex Japan 0.71

Sector Breakdown

breakdown chart
  Sector % of Fund
Biotechnology & Life Sciences Tools & Services 29.03
Pharmaceuticals 27.36
Managed Health Care, Health Care Services, Health Care Distributors 18.03
Health Care Equipment 13.32
Other 4.99
Cash 3.96
Health Care Facilities 3.31

All prices in Pence Sterling (GBX) unless otherwise specified. Price performance figures are calculated on a bid price to bid price basis with net income (dividends) reinvested. Performance figures are shown in Sterling.

Sign up for email alerts
Stay upto date on the latest fund research from FE
subscribe Readers of this page also looked at:
Readers of this have not looked at any others
Data provided by FE. Care has been taken to ensure that the information is correct, but FE neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.